ACSM3 and metabolic syndrome: In conclusion, the authors demonstrate that suppression of Acsm3 drives MetS by inducing hepatic mitochondrial dysfunction in a lauric acid-Hnf4α-p38-MAPK-dependent pathway (Fig. 1, Right Panel).